Actively Recruiting
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
Led by Guangdong Provincial People's Hospital · Updated on 2024-07-12
118
Participants Needed
1
Research Sites
198 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The goal of this single-center prospective randomized controlled trial is to test and compare the safety and effectiveness of autologous blood transfusion in spinal surgery for lung cancer spinal metastases. The main questions it aims to answer are: * Does autologous blood transfusion increase the incidence of new metastases? * Does autologous blood transfusion affect postoperative hemoglobin levels and the number of circulating tumor cells in the blood? * Can autologous blood transfusion reduce the rate of allogeneic transfusion during and after surgery for spinal metastases?
CONDITIONS
Official Title
The Safety and Efficacy of Autologous Transfusion in Spinal Surgery for Lung Cancer With Spinal Metastasis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age between 18 and 75 years old
- Pathological diagnosis of lung cancer with spinal metastatic tumor
- Expected survival greater than 3 months and able to tolerate surgery
- Unstable spine and/or spinal cord nerve compression with progressive nerve function decline
- Undergoing palliative open spinal decompression surgery
- Intraoperative or postoperative hemoglobin less than 90 g/L or other conditions requiring blood transfusion
You will not qualify if you...
- Serious heart dysfunction or heart failure
- Diagnosed blood system diseases or coagulation disorders
- Severe renal insufficiency or need for hemodialysis treatment
- Sepsis or septicemia
- Unable to provide consent from the patient or family
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Guangdong provincial people's hospital
Guangzhou, Guangdong, China, 516008
Actively Recruiting
Research Team
Y
Yu Zhang, Ph.D.
CONTACT
G
Guoqing Zhong, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here